secwatch.observer — SEC 8-K summary
======================================

Issuer:     Unicycive Therapeutics, Inc. (UNCY)
CIK:        0001766140
Form:       8-K
Filed at:   2024-07-15T23:59:59+00:00
Accession:  0001213900-24-061354
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Unicycive Therapeutics receives Nasdaq bid price deficiency notice; 180 days to regain compliance
--------------------------------------------------------------------------------

- Received Nasdaq notice on July 9, 2024 for bid price below $1.00 for 30 consecutive business days.
- Has until January 6, 2025 to regain compliance by closing at $1.00+ for ten consecutive business days.
- Stock continues trading on Nasdaq Capital Market under symbol UNCY; company may consider options.
- If not compliant by Jan 6, 2025, may qualify for second 180-day period or face delisting with appeal rights.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1766140/000121390024061354/0001213900-24-061354-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1766140/000121390024061354/ea0209297-8k_unicycive.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-061354

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer